KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Teva Pharmaceutical Industries (TEVA) over the last 15 years, with Q4 2025 value amounting to $1.1 billion.

  • Teva Pharmaceutical Industries' Prepaid Assets rose 1153.08% to $1.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.1 billion, marking a year-over-year increase of 1153.08%. This contributed to the annual value of $1.1 billion for FY2025, which is 1153.08% up from last year.
  • Teva Pharmaceutical Industries' Prepaid Assets amounted to $1.1 billion in Q4 2025, which was up 1153.08% from $1.1 billion recorded in Q3 2025.
  • Over the past 5 years, Teva Pharmaceutical Industries' Prepaid Assets peaked at $1.3 billion during Q1 2024, and registered a low of $942.0 million during Q1 2021.
  • In the last 5 years, Teva Pharmaceutical Industries' Prepaid Assets had a median value of $1.1 billion in 2024 and averaged $1.1 billion.
  • Per our database at Business Quant, Teva Pharmaceutical Industries' Prepaid Assets surged by 1910.61% in 2021 and then crashed by 2380.24% in 2025.
  • Over the past 5 years, Teva Pharmaceutical Industries' Prepaid Assets (Quarter) stood at $1.1 billion in 2021, then increased by 8.09% to $1.2 billion in 2022, then rose by 8.0% to $1.3 billion in 2023, then fell by 19.84% to $1.0 billion in 2024, then increased by 11.53% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q4 2025, $1.1 billion for Q3 2025, and $1.1 billion during Q2 2025.